What is HC Wainwright’s Forecast for CNTX Q2 Earnings?
Context Therapeutics Inc. (NASDAQ:CNTX – Free Report) – Equities research analysts at HC Wainwright decreased their Q2 2025 earnings per share estimates for shares of Context Therapeutics in a note issued to investors on Thursday, May 8th. HC Wainwright analyst E. Bodnar now expects that the company will earn ($0.05) per share for the quarter, […]
Context Therapeutics Inc. (NASDAQ:CNTX – Free Report) – Equities research analysts at HC Wainwright decreased their Q2 2025 earnings per share estimates for shares of Context Therapeutics in a note issued to investors on Thursday, May 8th. HC Wainwright analyst E. Bodnar now expects that the company will earn ($0.05) per share for the quarter, […]
